1. Home
  2. KF vs SWKH Comparison

KF vs SWKH Comparison

Compare KF & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korea Fund Inc. (The) New

KF

Korea Fund Inc. (The) New

HOLD

Current Price

$49.60

Market Cap

197.9M

Sector

Finance

ML Signal

HOLD

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

HOLD

Current Price

$17.00

Market Cap

205.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KF
SWKH
Founded
1984
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Diversified Financial Services
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
197.9M
205.9M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
KF
SWKH
Price
$49.60
$17.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
18.4K
6.3K
Earning Date
01-01-0001
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
120.89
EPS
N/A
1.85
Revenue
N/A
$40,149,000.00
Revenue This Year
N/A
$52.93
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.18
Revenue Growth
N/A
62.38
52 Week Low
$18.30
$13.17
52 Week High
$25.56
$20.49

Technical Indicators

Market Signals
Indicator
KF
SWKH
Relative Strength Index (RSI) 72.46 39.13
Support Level $45.21 $16.73
Resistance Level $49.89 $17.41
Average True Range (ATR) 1.46 0.18
MACD -0.00 -0.05
Stochastic Oscillator 69.21 40.23

Price Performance

Historical Comparison
KF
SWKH

About KF Korea Fund Inc. (The) New

Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and Others.

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Share on Social Networks: